Our mission is to develop, manufacture and distribute, to healthcare establishments all over the world, injectable medicines which help to improve the healthcare offer and save lives.
Panpharma – a specialist in the injectable medicines sector
Our Group is known for its recognised expertise in the development, production and marketing of injectable medicines for use in healthcare establishments.
News
- Panpharma Invests to Strengthen Its Injectable Penicillin Production in Brittany, FranceBetween 2022 and 2025, Panpharma successfully managed a large-scale project involving the construction of new buildings and the installation of state-of-the-art production equipment dedicated to …
- Panpharma is modernizing its production by investing in a new vial filling line for injectable forms at its Trittau site in Germany.The launch of this new line is scheduled for late 2025, following inspections by the relevant authorities. Several qualification tests have already been carried out, …
- Panpharma acquires Bayer’s marketing authorisation for injectable acetylsalicylic acid in GermanyAfter obtaining European marketing authorisations (MA) for Sanofi’s injectable acetylsalicylic acid (formerly Kardegic® and Aspegic® injectables) a year earlier, Panpharma reached another major milestone at …
A global presence
Established in France, in 1983, the Panpharma Group has become one of the French market leaders. At the same time we have grown rapidly on an international level, now present in more than 100 countries.
Innovate to meet the needs of healthcare professionals and patients
To meet the needs of healthcare establishments and patients, we dedicate a substantial part of our resources to research and development.
A company which is responsible and committed
Health
Social
Environment
Our diversity of talent and our strength
At Panpharma, we mobilise our resources and skills to operate in a socially responsible manner for the long term.
